Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Transpl Immunol. 2012 Jan;26(1):34-41. doi: 10.1016/j.trim.2011.09.004. Epub 2011 Sep 22.
Mixed chimerism has been suggested to induce tolerance to transplanted alloantigens. As the precise influence of mixed chimerism induction on the host organism has still not been fully elucidated, the aim of the present study was to explore this phenomenon in relation to the stem cell compartment. The experiment was performed on B6.SJL-Ptprc(a)Pep3(b) mice. Mixed chimerism induction protocols involved 3 Gy TBI (Day -1 of the experiment), injection of 20-30 × 10(6) Balb C bone marrow cells (Day 0), and administration of blocking antibodies against CD40L (Day 0 and Day 4), anti-CD8 (Day -2) with/without anti-NK1.1 (Day -3). Selected groups of mice were also treated with cyclophosphamid (175 mg/kg) on Day 2. The presence of mixed chimerism was assessed in peripheral blood, bone marrow, and spleen, as well as in various subpopulations of leukocytes (CD4(+), CD8(+), CD45/B220(+), Gr-1(+), lin(-)/Sca-1(+)/c-kit(-), lin(-)/Sca-1(+)/c-kit(+), lin(-)/Sca-1(-)/c-kit(+)). Furthermore, the percentage of stem/progenitor cells (lin(-)/Sca-1(+)/c-kit(-), lin(-)/Sca-1(+)/c-kit(+), lin(-)/Sca-1(-)/c-kit(+), VSEL, HSC) was analysed for the first time in bone marrow and peripheral blood of chimeric mice. The range of mixed chimerism differed significantly among various cell populations: it was lowest in CD8-positive cells and lin(-)/Sca-1(+)/c-kit(-) cells, and highest in granulocytes. The induction of mixed chimerism revealed a significant impact on the stem/progenitor cell frequency in recipient mice, providing potential therapeutic insights into the long-term immunologic tolerance observed in chimeric mice. Collectively, these findings contribute to further optimization of mixed chimerism induction protocols and might help in the introduction of this phenomenon into clinical practice.
嵌合体已被证明可以诱导对移植同种抗原的耐受。由于混合嵌合体诱导对宿主的精确影响尚未完全阐明,本研究的目的是探讨这种现象与干细胞隔室的关系。该实验在 B6.SJL-Ptprc(a)Pep3(b) 小鼠上进行。混合嵌合体诱导方案包括 3 Gy TBI(实验的第-1 天)、注射 20-30×10^6 只 Balb C 骨髓细胞(第 0 天)以及阻断性抗 CD40L 抗体(第 0 天和第 4 天)、抗 CD8 抗体(第-2 天)联合/不联合抗 NK1.1 抗体(第-3 天)。选定的小鼠组还在第 2 天接受环磷酰胺(175mg/kg)治疗。外周血、骨髓和脾脏中的混合嵌合体以及白细胞的各种亚群(CD4(+)、CD8(+)、CD45/B220(+)、Gr-1(+)、lin(-)/Sca-1(+)/c-kit(-)、lin(-)/Sca-1(+)/c-kit(+)、lin(-)/Sca-1(-)/c-kit(+))中均评估了嵌合体的存在。此外,首次分析了嵌合小鼠骨髓和外周血中干细胞/祖细胞(lin(-)/Sca-1(+)/c-kit(-)、lin(-)/Sca-1(+)/c-kit(+)、lin(-)/Sca-1(-)/c-kit(+)、VSEL、HSC)的百分比。各种细胞群中的混合嵌合体范围差异显著:CD8 阳性细胞和 lin(-)/Sca-1(+)/c-kit(-)细胞中的混合嵌合体最低,粒细胞中的混合嵌合体最高。混合嵌合体的诱导对受者小鼠的干细胞/祖细胞频率有显著影响,为嵌合小鼠中观察到的长期免疫耐受提供了潜在的治疗见解。总之,这些发现有助于进一步优化混合嵌合体诱导方案,并可能有助于将这种现象引入临床实践。